Aduhelm's accelerated approval for the treatment of Alzheimer's disease
J Pak Med Assoc
.
2022 Feb;72(2):395.
doi: 10.47391/JPMA.4368.
Authors
Aayat Ellahi Buksh
1
,
Fahd Niaz Shaikh
2
,
Muhammad Hasnain Mankani
3
Affiliations
1
First Year MBBS Student, Jinnah Sindh Medical University, Karachi, Pakistan.
2
Second Year MBBS Student, Dow University of Health Sciences, Karachi, Pakistan.
3
First Year MBBS Student, The Aga Khan University, Karachi, Pakistan.
PMID:
35320208
DOI:
10.47391/JPMA.4368
No abstract available
MeSH terms
Alzheimer Disease* / drug therapy
Antibodies, Monoclonal, Humanized
Humans
Substances
Antibodies, Monoclonal, Humanized
aducanumab